Penserra Capital Management’s Cano Health, Inc. CANO Stock Holding History

Penserra Capital Management’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-91	Closed	-$39K	–	1324
2022 Q2	$39K	Buy	91 +1	+1%	+$521	﹤0.01%	961
2022 Q1	$56K	Sell	90 -20	-18%	-$12.6K	﹤0.01%	977
2021 Q4	$97K	Sell	110 -42	-28%	-$44.1K	﹤0.01%	843
2021 Q3	$192K	Sell	152 -31	-17%	-$37.6K	﹤0.01%	630
2021 Q2	$221K	Sell	183 -185	-50%	-$250K	﹤0.01%	626
2021 Q1	$488K	Buy	368 +181	+97%	+$256K	0.01%	447
2020 Q4	$250K	Buy	+187	New	+$214K	0.01%	493

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Penserra Capital Management's CANO Position: Q3 2022 in Review

Penserra Capital Management sold out of Cano Health, Inc. (CANO) in Q3 2022, closing a stake of 91 shares — an estimated $39K sold.

Penserra Capital Management first reported a position in CANO in Q4 2020 and held it in 7 quarters. The position peaked at $488K in Q1 2021. 173 funds tracked by Wall St. Rank hold CANO as of Q3 2022.

Penserra Capital Management reported no remaining Cano Health, Inc. position as of Q3 2022 after selling out during the quarter.
Penserra Capital Management sold 91 Cano Health, Inc. shares in Q3 2022, an estimated $39K.
Penserra Capital Management first reported a position in Cano Health, Inc. in Q4 2020 and held it in 7 quarters.
Penserra Capital Management's Cano Health, Inc. position peaked at $488K in Q1 2021.
173 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.